Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis
Go back to Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bay National Corporation (AMEX: BAYN) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.04 | |||
| Open | $61.11 | 52 Week Low | $0.03 | |||
| Day High | $0.01 | P/E | 0.00 | |||
| Day Low | $0.01 | EPS | $-8.34 | |||
| Volume | 358,028 | |||||
| Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) | Delayed: 10.95 +0.14 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.81 | 52 Week High | $135.54 | |||
| Open | $11.06 | 52 Week Low | $94.36 | |||
| Day High | $11.09 | P/E | N/A | |||
| Day Low | $10.91 | EPS | $0.00 | |||
| Volume | 389,366 | |||||
| Bayer AG (AMEX: BAYZF) | Delayed: 44.07 +0.91 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.16 | 52 Week High | $135.00 | |||
| Open | $44.24 | 52 Week Low | $94.95 | |||
| Day High | $44.24 | P/E | N/A | |||
| Day Low | $44.07 | EPS | $0.00 | |||
| Volume | 1,255 | |||||

